GxP Frame Publicationshttps://www.gxpframe.com/insights2026-05-27T00:00:00ZBrian DrapeauThe CDMO Training Crisis: Why the $52 Billion Cell & Gene Therapy Market Can't Scale Without Better Traininghttps://www.gxpframe.com/insights-cdmo-training-crisis2026-05-27T00:00:00Z2026-05-27T00:00:00ZCDMO training is the bottleneck for cell and gene therapy growth. Why multi-client chaos and turnover break programs, and the architecture that fixes them.FDA CMC Flexibility for CGT Manufacturers: Here's Why Most Will Use It Wronghttps://www.gxpframe.com/insights-fda-cgt-flexibility2026-04-03T00:00:00Z2026-04-03T00:00:00ZFDA CMC flexibility for cell and gene therapy is real, but it demands more process understanding, not less. Why most will misuse it and how to stay ready.Pharma LMS Implementation: Your LMS Is Either Your Greatest Asset or Your Most Expensive Filing Cabinethttps://www.gxpframe.com/insights-lms-greatest-asset2026-02-13T00:00:00Z2026-02-13T00:00:00ZPharma LMS implementation and administration decide whether your LMS is a training asset or an expensive filing cabinet. Here is what good looks like.The SOP Authoring Trap: Why Your Procedures Don't Work on the Floorhttps://www.gxpframe.com/insights-sop-authoring-trap2026-02-12T00:00:00Z2026-02-12T00:00:00ZSOP authoring fails when the wrong people write for the wrong audience in the wrong format. Why procedures break on the floor and a better way to write them.AI Training in Biopharma: What's Real, What's Hype, and What You Need to Know Nowhttps://www.gxpframe.com/insights-ai-training-revolution-biopharma2026-02-11T00:00:00Z2026-02-11T00:00:00ZAI training in biopharma: a practitioner's look at what is deployed, what is promising, and what is still hype, plus what training managers should do now.Why Your GMP Training Program Is a Ticking Time Bomb (And What to Do About It)https://www.gxpframe.com/insights-training-time-bomb2026-02-09T00:00:00Z2026-02-09T00:00:00ZIs your GMP training program a ticking time bomb? What FDA Form 483s and warning letters reveal about training deficiencies, plus solutions that actually work.Building a Biotech Startup Training Program: A Survival Guidehttps://www.gxpframe.com/insights-biotech-startup-training2026-02-07T00:00:00Z2026-02-07T00:00:00ZBuilding a biotech startup training program without cutting corners: what to build first, what can wait, and the costly mistakes startups make later on.